GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,640.50p
   
  • Change Today:
      4.50p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 5,015,380
  • Market Cap: £67,997m
  • RiskGrade: 129

Regulatory News

US FDA accepts new indication filing for Jemperli 24-Apr-2024 07:00 RNS
Director/PDMR Shareholding 19-Apr-2024 15:30 RNS
Director/PDMR Shareholding 17-Apr-2024 15:30 RNS
GSK announces additional EAGLE-1 results 17-Apr-2024 07:05 RNS
Results from long-term data relating to Shingrix 17-Apr-2024 07:00 RNS
Amendment - Director/PDMR Shareholding 16-Apr-2024 14:11 RNS
FDA accepts GSK meningitis vaccine candidate file 16-Apr-2024 07:00 RNS
Director/PDMR Shareholding 15-Apr-2024 15:30 RNS
Replacement - Total Voting Rights 04-Apr-2024 12:05 RNS
Total Voting Rights 02-Apr-2024 15:00 RNS
Director/PDMR Shareholding 26-Mar-2024 15:30 RNS
Notice of AGM 25-Mar-2024 13:00 RNS
Transfer of Treasury Shares 22-Mar-2024 16:20 RNS
Director/PDMR Shareholding 22-Mar-2024 15:36 RNS
New Phase III Jemperli data in endometrial cancer 18-Mar-2024 09:30 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,640.50p
Change Today 4.50p
% Change 0.28 %
52 Week High 1,711.20
52 Week Low 1,316.00
Volume 5,015,380
Shares Issued 4,144.88m
Market Cap £67,997m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
80.75% below the market average80.75% below the market average80.75% below the market average80.75% below the market average80.75% below the market average
81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average
Price Trend
27.71% above the market average27.71% above the market average27.71% above the market average27.71% above the market average27.71% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
44.18% above the market average44.18% above the market average44.18% above the market average44.18% above the market average44.18% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
24.45% below the market average24.45% below the market average24.45% below the market average24.45% below the market average24.45% below the market average
51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 25-Apr-2024

Time Volume / Share Price
16:35 1,722,703 @ 1,640.50p
16:35 157 @ 1,640.50p
16:35 395 @ 1,640.50p
16:35 474 @ 1,640.50p
16:35 2,215 @ 1,640.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page